Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$29,135,188
+$21,028,440 QoQ
Shares Held
185,906
+250.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#88
of 1,603 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $567,998,433 across 14 Drug Manufacturers - General names. NVS ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
118,181 | $141,749,848 | |
| 2 | JNJ |
Johnson & Johnson
|
456,860 | $116,028,734 | |
| 3 | ABBV |
AbbVie Inc.
|
426,678 | $107,369,251 | |
| 4 | PFE |
Pfizer Inc
|
1,884,553 | $45,380,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
323,733 | $41,599,690 | |
| 6 | NVS |
Novartis AG
This page
|
185,906 | $29,135,188 | |
| 7 | AMGN |
Amgen Inc
|
79,199 | $28,679,541 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
229,499 | $13,223,732 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,135,188 | 185,906 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,106,748 | 53,072 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,528,971 | 47,356 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,898,573 | 69,390 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,595,449 | 29,712 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,304,155 | 29,639 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,671,117 | 37,726 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,709,679 | 188,747 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,100,286 | 188,806 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,454,228 | 35,710 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,121,992 | 30,920 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,020,556 | 29,654 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,305,058 | 62,482 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,976,384 | 32,352 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,351,021 | 47,961 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,514,221 | 72,546 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $3,216,112 | 38,047 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,965,950 | 33,800 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $5,548,222 | 63,430 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $9,254,879 | 113,168 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $6,025,580 | 66,041 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $5,844,951 | 68,378 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $11,241,230 | 119,043 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $5,137,422 | 59,078 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||